Literature DB >> 8948388

Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake.

M Boaz1, S Smetana.   

Abstract

OBJECTIVE: To develop a predictive equation for dietary phosphorus intake.
DESIGN: In this clinic-based, cross-sectional study, a dietitian-administered food frequency questionnaire provided dietary intake estimates for a population of patients with chronic renal failure. A prediction equation for dietary phosphorus intake was developed and was validated on another sample of patients with CRF from the same clinic.
SUBJECTS: Outpatients treated for chronic renal failure at the E. Wolfson Medical Center Institute of Nephrology in Holon, Israel, participated in the study (N = 104, 73 men and 31 women, mean age = 65.6 years). The validation sample consisted of 53 outpatients with chronic renal failure (38 men and 15 women, mean age = 64.2 years) from the same clinic. MAIN OUTCOME MEASURES: Dietary variables (ie, energy, protein, carbohydrate, fat, phosphorus) were examined in terms of crude intake, as percentage of total energy intake, and per kilogram of body weight. STATISTICAL ANALYSES PERFORMED: Stepwise linear regression analysis and Student's t tests were used to examine relationships between dietary phosphorus and other variables.
RESULTS: Dietary phosphorus (milligrams) = 128 + 14 (protein intake [grams]) was the best-fitting equation and explained 84% of the variance in dietary phosphorus intake. APPLICATIONS: The prediction equation for dietary phosphorus intake is especially useful for renal dietitians who calculate patient diets by hand.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948388     DOI: 10.1016/S0002-8223(96)00331-8

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  19 in total

1.  Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives.

Authors:  Adamasco Cupisti; Omar Benini; Valerio Ferretti; Daniela Gianfaldoni; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2012-03-09       Impact factor: 3.655

2.  Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.

Authors:  George A Kaysen; Brett Larive; Patricia Painter; Alexander Craig; Robert M Lindsay; Michael V Rocco; John T Daugirdas; Gerald Schulman; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

3.  Dietary phosphorus intake and distribution in Chinese peritoneal dialysis patients with and without hyperphosphatemia.

Authors:  Na Jiang; Wei Fang; Xiaoxiao Yang; Lin Zhang; Jiangzi Yuan; Aiwu Lin; Zhaohui Ni; Jiaqi Qian
Journal:  Clin Exp Nephrol       Date:  2014-09-05       Impact factor: 2.801

Review 4.  Reexamining the Phosphorus-Protein Dilemma: Does Phosphorus Restriction Compromise Protein Status?

Authors:  David E St-Jules; Kathleen Woolf; Mary Lou Pompeii; Kamyar Kalantar-Zadeh; Mary Ann Sevick
Journal:  J Ren Nutr       Date:  2016-02-09       Impact factor: 3.655

Review 5.  Phosphate control in end-stage renal disease: barriers and opportunities.

Authors:  Ahmed A Waheed; Fernando Pedraza; Oliver Lenz; Tamara Isakova
Journal:  Nephrol Dial Transplant       Date:  2013-07-30       Impact factor: 5.992

Review 6.  Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.

Authors:  Elizabeth R Stremke; Annabel Biruete; Kathleen M Hill Gallant
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

Review 7.  Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.

Authors:  A Galassi; A Cupisti; A Santoro; M Cozzolino
Journal:  J Nephrol       Date:  2014-09-23       Impact factor: 3.902

Review 8.  Management of natural and added dietary phosphorus burden in kidney disease.

Authors:  Adamasco Cupisti; Kamyar Kalantar-Zadeh
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

Review 9.  The role of phosphate in kidney disease.

Authors:  Marc G Vervloet; Siren Sezer; Ziad A Massy; Lina Johansson; Mario Cozzolino; Denis Fouque
Journal:  Nat Rev Nephrol       Date:  2016-11-21       Impact factor: 28.314

10.  Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients.

Authors:  Alastair J Hutchison; Maggie Gill; J Brian Copley; Lynne Poole; Rosamund J Wilson
Journal:  BMC Nephrol       Date:  2013-02-18       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.